InsidersTradesSigma
Track the Vimian Group AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Vimian Group AB has published 0 reports. Market capitalisation: €17.7bn. All data is openly available.
Analysts rate Vimian Group AB Buy (bullish), based on 6 analysts. Average price target: SEK 35.72.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Vimian Group AB is a company focused on the health and pharmaceutical sector. It is listed on the Stockholm Stock Exchange (XSTO).